Skip to main content

Table 1 Patient characteristics (n = 194)

From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

 

Total

 

n = 194

Age at time of PET/CT (years), median (IQR)

70.0 (63.0–75.0)

Most recent PSA prior to PET/CT (ng/mL), median (IQR)

10.0 (6.5–18.0)

PSA groups (ng/mL) (n = 194)

 

  ≤10

101 (52.1%)

10 –20

50 (25.8%)

 > 20

43 (22.2%)

ISUP grade (n = 189)

 

1

8 (4.2%)

2

41 (21.7%)

3

50 (26.5%)

4

34 (18.0%)

5

56 (29.6%)

Previous/current ADT prior to the PET/CT scan

14 (7.2%)

Duration of ADT prior to PET/CT scan (months), median (IQR) (n = 14)

2.0 (2.0–5.0)

  1. Data presented as median (IQR) for continuous variables and n (%) for categorical variables; n = number; ADT = Androgen Deprivation Therapy; IQR = interquartile range